Medicare IVIG Access Enhancement Act
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (May 22, 2019)
Medicare IVIG Access Enhancement Act
This bill requires the Centers for Medicare & Medicaid Services to establish a three-year demonstration project to evaluate the benefits of providing Medicare coverage and payment for items and services needed for the in-home administration of intravenous immune globulin to treat chronic inflammatory demyelinating polyneuropathy or multifocal motor neuropathy. Beneficiary participation shall be voluntary.
What just happenedMay 23, 2019
Referred to the Subcommittee on Health.
Who’s behind it
- Introduced in HouseMay 22, 2019
- May 23, 2019Committee
Referred to the Subcommittee on Health.
Health Subcommittee - May 23, 2019Committee
Referred to the Subcommittee on Energy.
Energy, Climate and Grid Security Subcommittee - May 22, 2019IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Ways and Means Committee - May 22, 2019IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Energy and Commerce Committee - May 22, 2019IntroReferralB00100
Sponsor introductory remarks on measure. (CR E657)
- May 22, 2019IntroReferralIntro-H
Introduced in House
- May 22, 2019IntroReferral1000
Introduced in House